We used NGS to quantify antibiotic resistance genes in poop samples collected from 49 kids with acute lymphoblastic leukemia before and after intensive induction chemotherapy. All got trimethoprim-sulfamethoxazole (Bactrim or Septra) prophylaxis and some also got levofloxacin.
We found *all* kids had a massive increase in abundance of genes conferring resistance to trimethoprim-sulfamethoxazole, which is universally used to prevent Pneumocystis pneumonia (PCP). [P<0.0001]
But, *only* kids who received the levofloxacin prophylaxis had a significant increase in the prevalence of gene mutations that confer fluoroquinolone resistance. [P<0.0001]
There was *no other difference* in resistance genes between kids who got levofloxacin prophylaxis or not.
This is kind of reassuring. We had been worried that levofloxacin prophylaxis might increase *cross-resistance* to other antibiotics, but it seems like it doesn't. It does make us worried about long-term effectiveness, though.
This work was done by an amazing team, none of whom are on Twitter AFAIK!!!!
You can follow @Joshuawolf.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.